TITLE

Here come the drugs

PUB. DATE
April 2004
SOURCE
U.S. Catholic;Apr2004, Vol. 69 Issue 4, p10
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports on the free antiretroviral drugs given by the Catholic Church to South Africans infected with HIV and AIDS. Number of South Africans infected; Plan for the church-run projects for the drugs; Statement from Bishop Kevin Dowling about the proposed antiretroviral drug program from the South African government.
ACCESSION #
12916794

 

Related Articles

  • Tenofovir and Nephrotoxicity. Joshi, Amit; Kraus, Mark // Kidney;Nov/Dec2005, Vol. 14 Issue 6, p255 

    The article provides information on the development of antiretroviral drug tenofovir for the treatment of HIV/AIDS. Tenofovir is an acyclic nucleoside phosphonate in the class of nucleotide reverse transcriptase inhibitors. The drug interrupts DNA synthesis by terminating the elongation of the...

  • Randomized, Controlled Trial of Therapy Interruption in Chronic HIV-1 Infection. Papasavvas, Emmanouil; Kostman, Jary R.; Mounzer, Karam; Grant, Robert M.; Gross, Robert; Gallo, Cele; Azzoni, Livio; Foulkes, Andrea; Thiel, Brian; Pistilli, Maxwell; Mackiewicz, Agnieszka; Shull, Jane; Montaner, Luis J. // PLoS Medicine;Dec2004, Vol. 1 Issue 3, p218 

    Background Approaches to limiting exposure to antiretroviral therapy (ART) drugs are an active area of HIV therapy research. Here we present longitudinal follow-up of a randomized, open-label, single-center study of the immune, viral, and safety outcomes of structured therapy interruptions (TIs)...

  • A 96-Week Comparison of Lopinavir-Ritonavir Combination Therapy Followed by Lopinavir-Ritonavir Monotherapy versus Efavirenz Combination Therapy. Cameron, D. William; da^Silva, Barbara A.; Arribas, Jose R.; Myers, Robert A.; Bellos, Nicholaos C.; Gilmore, Norbert; King, Martin S.; Bernstein, Barry M.; Brun, Scott C.; Hanna, George J. // Journal of Infectious Diseases;7/15/2008, Vol. 198 Issue 2, p234 

    Antiretroviral-naive HIV-1-infected volunteers received zidovudine/lamivudine plus either lopinavir/ritonavir (n = 104) or efavirenz (n = 51). Lopinavir/ritonavir-treated subjects demonstrating 3 consecutive monthly HIV-1 RNA levels <50 copies/mL started lopinavir/ritonavir monotherapy. In...

  • Antiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected Persons. Pattacini, Laura; Murnane, Pamela M.; Baeten, Jared M.; Fluharty, Tayler R.; Thomas, Katherine K.; Bukusi, Elizabeth; Katabira, Elly; Mugo, Nelly; Donnell, Deborah; Lingappa, Jairam R.; Celum, Connie; Marzinke, Mark; McElrath, M. Juliana; Lund, Jennifer M. // Journal of Infectious Diseases;6/15/2015, Vol. 211 Issue 12, p1943 

    Background. Antiretroviral preexposure prophylaxis (PrEP), using daily oral combination tenofovir disoproxil fumarate plus emtricitabine, is an effective human immunodeficiency virus (HIV) prevention strategy for populations at high risk of HIV acquisition. Although the primary mode of action...

  • Review of antiretroviral agents for the treatment of HIV infection. Stanic, Anela; Grana, Julie C. // Formulary;Feb2009, Vol. 44 Issue 2, p47 

    Research into the treatment of HIV infection has resulted in the development of 5 antiretroviral (ARV) drug classes: entry inhibitors, including fusion inhibitors and chemokine coreceptor (CCR) inhibitors; nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs); non-nucleoside reverse...

  • Skip HIV therapy.  // New Scientist;8/12/2006, Vol. 191 Issue 2564, p7 

    The article focuses on research by Bernard Hirschel at the University Hospital of Geneva in Switzerland and his colleagues which revealed that people who take closely monitored breaks from highly active anti-retroviral therapy for HIV infection might also suffer fewer side effects. There are...

  • Relationship Between Routinization of Daily Behaviors and Medication Adherence in HIV-Positive Drug Users. Wagner, Glenn J.; Ryan, Gery W. // AIDS Patient Care & STDs;Jul2004, Vol. 18 Issue 7, p385 

    Although lifestyle factors and routinization of daily activities are emerging as important variables in understanding and improving medication adherence, measures of these constructs remain crude and rudimentary. This study evaluated whether a brief, yet more comprehensive measure of the...

  • Antiretroviral Strategies to Prevent Mother-to-Child Transmission of HIV: Striking a Balance between Efficacy, Feasibility, and Resistance. Lehman, Dara A.; John-Stewart, Grace C.; Overbaugh, Julie // PLoS Medicine;Oct2009, Vol. 6 Issue 10, p1 

    In this article, the authors discuss the efficacy, resistance and feasibility of antiretroviral strategies to prevent the mother-to-child transmission (MTCT) of HIV. They note that various short-course antiretroviral therapies are used to prevent the transmission. They consider zidovudine (AZT)...

  • Current HIV Treatment Guidelines - An Overview. Rathbun, R. C.; Lockhart, S. M.; Stephens, J. R. // Current Pharmaceutical Design;Apr2006, Vol. 12 Issue 9, p1045 

    Use of highly active antiretroviral therapy has resulted in significant reductions in HIV-related morbidity and mortality. Current therapeutic approaches target cellular entry, viral transcription, and maturation of newly formed virus. Combination therapy is necessary to provide durable...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics